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Influenza A viruses are characterized by their ability to evade host immunity, even in vaccinated individuals. To determine
how prior immunity shapes viral diversity in vivo, we studied the intra- and interhost evolution of equine influenza virus
in vaccinated horses. Although the level and structure of genetic diversity were similar to those in naïve horses, intrahost
bottlenecks may be more stringent in vaccinated animals, and mutations shared among horses often fall close to putative
antigenic sites.
Equine influenza virus (EIV) of the H3N8 subtype is a signifi-cant horse pathogen and an important example of influenza
emergence, as it recently transferred into dogs and became estab-
lished as a novel canine influenza virus (1). EIV is subject to strong
immunological pressure (2), and antigenic drift can result in out-
breaks of disease even in vaccinated horse populations (3). We
have previously studied the intrahost evolution of EIV in naïve
horses (4) andduring a field outbreak (5). To determine howprior
immunity impacts intra- and interhost EIV evolution within a
controlled experimental setting, we performed a transmission
study using vaccinated horses challenged with a heterologous EIV
(6) and examined the intra- and interhost genetic variation of the
hemagglutinin 1 (HA1) gene domain at different times postinfec-
tion. All animal work was performed under license from the
Home Office under the Animals (Scientific Procedures) Act 1986
following full ethical approval.
Welsh Mountain ponies were vaccinated with inactivated
whole virus prepared from the Eurasian strain A/equine/New-
market/2/93. Before the virus challenge experiment, antibody
levels in vaccinated horses were measured by single radial he-
molysis (SRH) (7) until most declined to 60 mm2, a value
normally low enough to allow natural infection, including in a
previous contact experiment (J. Mumford, unpublished data).
A “seeder” (S) horse (naïve to EIV) was experimentally inocu-
lated via nebulized aerosol (20 ml of log10 10
6.3/ml of 50% egg
infective dose [EID50]) of the American strain A/equine/New-
market/1/1993. The aim of this step was to readapt the egg-
grown inoculum to the horse. Two days later, the seeder horse
was housed with a vaccinated horse (V1). V1 was then removed
and housed with V2. This procedure was repeated until horse
V4, which did not show clinical signs of infection. For this
reason, V4 was cohoused with V3 and then moved to a stable
with V5. Throughout the study, each horse was cohoused with
the next recipient horse for 3 days. Infection of horses was
confirmed using an enzyme-linked immunosorbent assay
(ELISA)-based test to measure virus excretion (8). SRH was
used to detect seroconversion and confirm transmission. Clin-
ical signs were recorded daily, and nasal swabs were collected
and processed as previously described (4, 5). Nasal swabs were
RNA extracted, and viral copy numbers were determined by
qRT-PCR as described previously (4). The hemagglutinin gene
(HA1) was amplified by PCR from viral populations of suffi-
cient size with the exception of the sample obtained from horse
V4, which was amplified by heminested PCR because it exhib-
ited a low copy number (primers available on request). PCR
products were cloned and sequenced using capillary sequenc-
ing as described previously (4, 5, 9, 10).
Transmission was successful up to horse V4 (Fig. 1A), and
horses shed up to 106 viral copies/l of cDNA (Fig. 1C). All
horses except V4 showed mild signs of influenza infection and
seroconverted (data not shown). Horse V5was not infected (it did
not seroconvert, and no virus was detected in nasal swabs). Horses
V1, V3, and V4 shed less virus than horse V2 (Fig. 1C), the animal
with the lowest antibody levels before entering the transmission
chain (data not shown) and whose shedding pattern was higher
than that observed in the seeder horse.
We generated between 34 and 79 clonal HA1 sequences (a total
of 549,927 nucleotides) from 10 daily nasal swabs. HA1 sequences
were 903 nucleotides long and included all antigenic sites and the
receptor-binding domain. A summary analysis of intrahost vari-
ation is shown in Table 1. Overall, we detected 126 mutations,
which resulted in a mutation frequency of 2.3 104 mutations
per nucleotide site, similar to the value observed in naïve horses
(1.8 104) (4).Mutations were distributed throughout theHA1
segment (data not shown), and the ratio of nonsynonymous to
synonymous substitutions per site (dN/dS) for the whole data set
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(estimated using HyPhy [11]) was 0.84 and, hence, very similar to
the value (0.80) observed in naïve horses evaluated in a similar
manner (4).
To estimate changes in genetic diversity of within-host viral
populations, we compiled sequences from individual horses and
aligned themusing Se-Al (http://tree.bio.ed.ac.uk/software/seal/).
We calculated the mean pairwise distance (Table 1) using
PAUP* (Sinauer Associates, version 4.0b10) and inferred me-
dian joining networks using Network 4.6.00 (http://www
.fluxus-engineering.com/sharenet.htm) to visualize the struc-
ture of the mutational spectra. All data sets resulted in star-like
phylogenies (Fig. 1B) in which most sequences were identical
to each other and had no evidence of evolution through sec-
ondary branching events, and mutant clones usually differed at
one nucleotide with respect to the consensus sequence. Such
phylogenetic structure is similar to that observed in naïve ani-
mals (4). We further divided all haplotypes by (i) host, (ii)
sampling day, and (iii) viral population (host and day) and
measured the overall differentiation in the data set as described
previously (12) using Dest (13). We observed small but signifi-
cant levels of subpopulation differentiation when samples were
divided by viral population (0.0010; P  0.026) but not by
sampling day (0.0004; P 0.128) and almost-significant values
when divided by horse (0.0010; P  0.057). Accordingly, we
infer that interhost transmission plays a role in shaping pat-
terns of intrahost diversity of EIV by allowing the generation of
“private” mutations. In addition, some variants (14%) dis-
played nonsynonymous mutations at putative antigenic and
FIG 1 Intra- and interhost genetic variation of EIV in vaccinated horses. (A) Layout of the transmission chain (see main text). S, seeder; V1 to V5, vaccinated
horses. The number refers to the order inwhich animals were introduced into the transmission chain.No virus was detected in horse V5 (shownwith a stop sign).
(B) Median joining networks derived from the horses included in the study. Each network was inferred by compiling sequences from all available days. The size
of each circle is proportional to the frequency of identical sequences in the data set, and the number of sequences that constitute the consensus is indicated. The
identification number of each horse is indicated at the bottom of each panel. Colors indicate the day in which the sample was taken relative to the day of contact.
(C) Estimation of viral copy numbers from individual swabs by real-time PCR.
TABLE 1 Analysis of intrahost variation of EIV in vaccinated horses
Horse Day
No. of
sequences
No. of
mutations
Mean
pairwise
distance
Mean
dN/dS
No. of
stop
codons
No. of
mutations
in Ag
sitesa
S 3 65 7 0.00023 0.38 0 2
4 71 11 0.00034 0.62 0 1
5 63 13 0.00045 0.49 0 0
V1 4 66 11 0.00037 0.51 1 0
6 45 7 0.00034 NAb 0 2
V2 3 79 7 0.00019 0.72 0 1
4 65 19 0.00063 0.61 1 2
5 74 10 0.0003 0.38 2 2
V3 3 34 3 0.00019 0.57 0 0
V4 5 47 38 0.00179 1.75 0 5
a Ag, antigenic.
b NA, not applicable.
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glycosylation sites as well as at the receptor-binding domain
(data not shown) such that they were able to exhibit altered
antigenicity and/or host range, although the observation that
they were present only as singleton mutations suggests that
positive selection had little effect on their frequency. Notably,
no mutations were present on multiple days from the same
horse, suggesting the presence of strong intrahost population
bottlenecks between sampling points. Despite this, we did de-
tect common mutations in different animals, and it is striking
that all of these common mutations were nonsynonymous and
fell either at putative antigenic sites (14) or very close to them
(within a range of nine amino acids) (Table 2).
We next examined the impact of prior immunity on within-
host viral populations by determining the variation of the HA1
gene of EIV in vaccinated horses. The levels of variation (mean
pairwise distances and mutation frequency), the topology of the
inferred trees, and the dN/dS ratio that we observed are similar to
those previously reported in naïve horses (4), in vaccinated horses
naturally infected during an outbreak of EIV (5), and in a previous
study on the evolution of a swine influenza virus (SIV) in naïve
and vaccinated pigs (10). Hence, the rapid production and turn-
over of mutations are the dominant signals in intrahost popula-
tions of influenza virus, regardless of the genetic background of
the virus and the immune status of its host. Itmay be that the effect
of prior immunity (presumably principally effected through cir-
culating antibody) is simply to dampen the rates of replication in
a relatively nonspecific manner prior to the initiation of an adap-
tive immune response at the site of infection. Any time lag de-
pends on various factors, such as the size of the resident memory
cell population, the match between viruses during past and cur-
rent infections, the time elapsed between infections, and the local
inflammatory response (15), which, in turn, may be differentially
modulated depending on the virus strain.
However, while mutational dynamics appear to be similar be-
tween vaccinated and naïve animals, our study did reveal two fac-
tors that might reflect the impact of prior immunity on within-
host viral populations (although the small number of animals
precludes definitive conclusions). First, within-host bottlenecks
seem to be more stringent in vaccinated animals, as we did not
observe any mutations that persisted between sampling times, in
contrast to previous studies of naïve animals (4, 10). Although it is
possible that suchmutations were present but not detected due to
insufficient sequencing depth, this evolutionary pattern is similar
towhatwas previously observed in SIV in vaccinated pigs (10) and
suggests that viral clearance within the host might be more effi-
cient in vaccinated animals. Second, all of the mutations that are
shared between horses were located at or very near putative anti-
genic sites, although it is unclear whether they are convergent,
representing similar selection pressures among horses, or are
transmitted among them as minor subpopulations. Further stud-
ies with a larger number of animals and deeper coverage (i.e.,
ultradeep sequencing) should be performed to confirm this find-
ing. Overall, our results highlight the significance of studying in-
fluenza infections in natural hosts with prior immunity, as they
can shed light on the underpinning mechanisms that govern ge-
netic (and likely antigenic) variation and thus provide insight on
strain selection for the development of more-effective vaccines.
Nucleotide sequence accession numbers. The clonal HA1 se-
quences generated from the daily nasal swabs were deposited in
GenBank under accession numbers KC295823 to KC296431.
ACKNOWLEDGMENTS
We thank JosephHughes for help with the figures andMariana Varela for
critically reading the manuscript.
P.R.M. was funded by the Wellcome Trust and the Medical Research
Council of the United Kingdom. E.C.H. was funded by grant R01
GM080533-06 from the National Institutes of Health and a National
Health andMedical Research Council Australia Fellowship. J.L.N.W. was
funded by Alborada Trust. B.T.G. and J.L.N.W. were supported by the
RAPIDD program of the Science & Technology Directorate, Department
of Homeland Security, and the Fogarty International Center, National
Institutes of Health. The work was supported by grant VT0105 from
DEFRA and HEFCE under the Veterinary Training and Research Initia-
tive to the Cambridge Infectious Disease Consortium.
REFERENCES
1. Crawford PC, Dubovi EJ, Castleman WL, Stephenson I, Gibbs EP,
Chen L, Smith C, Hill RC, Ferro P, Pompey J, Bright RA, Medina
MJ, Johnson CM, Olsen CW, Cox NJ, Klimov AI, Katz JM, Donis
RO. 2005. Transmission of equine influenza virus to dogs. Science
310:482–485.
2. Murcia PR, Wood JL, Holmes EC. 2011. Genome-scale evolution and
phylodynamics of equine H3N8 influenza A virus. J. Virol. 85:5312–5322.
3. Newton JR, Daly JM, Spencer L, Mumford JA. 2006. Description of the
outbreak of equine influenza (H3N8) in the United Kingdom in 2003,
during which recently vaccinated horses in Newmarket developed respi-
ratory disease. Vet. Rec. 158:185–192.
4. Murcia PR, Baillie GJ, Daly J, Elton D, Jervis C, Mumford JA, Newton
R, Parrish CR, Hoelzer K, Dougan G, Parkhill J, Lennard N, Ormond
D, Moule S, Whitwham A, McCauley JW, McKinley TJ, Holmes EC,
Grenfell BT, Wood JL. 2010. Intra- and interhost evolutionary dynamics
of equine influenza virus. J. Virol. 84:6943–6954.
5. Hughes J, Allen RC, Baguelin M, Hampson K, Baillie GJ, Elton D,
Newton JR, Kellam P, Wood JL, Holmes EC, Murcia PR. 2012. Trans-
mission of equine influenza virus during an outbreak is characterized by
frequent mixed infections and loose transmission bottlenecks. PLoS Pat-
hog. 8:e1003081. doi:10.1371/journal.ppat.1003081.
6. Daly JM, Yates PJ, Newton JR, Park A, Henley W, Wood JL, Davis-
Poynter N, Mumford JA. 2004. Evidence supporting the inclusion of
strains from each of the two co-circulating lineages of H3N8 equine influ-
enza virus in vaccines. Vaccine 22:4101–4109.
7. Wood JM, Mumford J, Folkers C, Scott AM, Schild GC. 1983. Studies
with inactivated equine influenza vaccine. 1. Serological responses of po-
nies to graded doses of vaccine. J. Hyg. (Lond.) 90:371–384.
8. Cook RF, Sinclair R, Mumford JA. 1988. Detection of influenza nucleo-
protein antigen in nasal secretions from horses infected with A/equine
influenza (H3N8) viruses. J. Virol. Methods 20:1–12.
9. Hoelzer K, Murcia PR, Baillie GJ, Wood JL, Metzger SM, Osterrieder N,
Dubovi EJ, Holmes EC, Parrish CR. 2010. Intrahost evolutionary dy-
namics of canine influenza virus in naive and partially immune dogs. J.
Virol. 84:5329–5335.
10. Murcia PR, Hughes J, Battista P, Lloyd L, Baillie GJ, Ramirez-Gonzalez
RH, Ormond D, Oliver K, Elton D, Mumford JA, Caccamo M, Kellam
P, Grenfell BT, Holmes EC, Wood JL. 2012. Evolution of an Eurasian
TABLE 2 EIV mutations present in multiple horses
Mutationa Motifb Horsesc (day)
A413G (E123G) AgA S (5), V4 (5)
T497A (L151Q) AgA S (3), V1 (6)
A614G (Q190R) AgB V1 (6), V2 (3)
T752C (I236T) AgD S (4), V2 (3)
A869G (D275G) AgC S (4), V4 (5)
a Amino acid numbering is based on mature HA3.
b Underlined motifs are located within nine amino acid residues of their respective
antigenic site.
c Horses are indicated as in Fig. 1.
Murcia et al.
4770 jvi.asm.org Journal of Virology
avian-like influenza virus in naive and vaccinated pigs. PLoS Pathog.
8:e1002730. doi:10.1371/journal.ppat.1002730.
11. Pond SL, Frost SD, Muse SV. 2005. HyPhy: hypothesis testing using
phylogenies. Bioinformatics 21:676–679.
12. Stack JC, Murcia PR, Grenfell BT, Wood JL, Holmes EC. 2013. Inferring
the inter-host transmission of influenza A virus using patterns of intra-
host genetic variation. Proc. Biol. Sci. 280:20122173.
13. Jost L. 2008. G(ST) and its relatives do not measure differentiation. Mol.
Ecol. 17:4015–4026.
14. Wiley DC, Skehel JJ. 1987. The structure and function of the hemagglu-
tinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem.
56:365–394.
15. Kohlmeier JE, Woodland DL. 2009. Immunity to respiratory viruses.
Annu. Rev. Immunol. 27:61–82.
EIV Evolutionary Dynamics
April 2013 Volume 87 Number 8 jvi.asm.org 4771
